ORBIMED ADVISORS LLC Insider Trading for June 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for June 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 456,870 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,351 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 77,697 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 739 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 380,986 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,628 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 14.00 | 544,811 | 7,627,354 | 1,825,415 | 1.3 M to 1.8 M (+42.54 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 14.00 | 5,189 | 72,646 | 17,382 | 12.2 K to 17.4 K (+42.56 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,166,884 | 0 | 1,280,604 | 113.7 K to 1.3 M (+1,026.10 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 11,111 | 0 | 12,193 | 1.1 K to 12.2 K (+1,026.89 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 456,870 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,351 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 77,697 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 739 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 380,986 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,628 | 0 | 0 | |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 14.00 | 544,811 | 7,627,354 | 1,825,415 | 1.3 M to 1.8 M (+42.54 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 14.00 | 5,189 | 72,646 | 17,382 | 12.2 K to 17.4 K (+42.56 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,166,884 | 0 | 1,280,604 | 113.7 K to 1.3 M (+1,026.10 %) |
| Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 11,111 | 0 | 12,193 | 1.1 K to 12.2 K (+1,026.89 %) |
| Jun 27 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.99 | 900 | 11,691 | 5,379,349 | 5.4 M to 5.4 M (+0.02 %) |
| Jun 27 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.92 | 100 | 1,292 | 5,378,449 | 5.4 M to 5.4 M (0.00 %) |
| Jun 21 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.87 | 26,083 | 335,688 | 5,378,349 | 5.4 M to 5.4 M (+0.49 %) |
| Jun 21 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.48 | 12,300 | 153,504 | 5,352,266 | 5.3 M to 5.4 M (+0.23 %) |
| Jun 20 2016 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.56 | 331,225 | 185,486 | 2,149,902 | 1.8 M to 2.1 M (+18.21 %) |
| Jun 20 2016 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.56 | 5,294 | 2,965 | 34,291 | 29 K to 34.3 K (+18.26 %) |
| Jun 20 2016 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.56 | 556,339 | 311,550 | 3,604,266 | 3 M to 3.6 M (+18.25 %) |
| Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.04 | 5,000 | 60,200 | 5,339,966 | 5.3 M to 5.3 M (+0.09 %) |
| Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 11.94 | 5,000 | 59,700 | 5,334,966 | 5.3 M to 5.3 M (+0.09 %) |
| Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.71 | 10,000 | 127,100 | 5,329,966 | 5.3 M to 5.3 M (+0.19 %) |
| Jun 13 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.98 | 20,000 | 259,600 | 5,319,966 | 5.3 M to 5.3 M (+0.38 %) |
| Jun 13 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.95 | 30,000 | 388,500 | 5,299,966 | 5.3 M to 5.3 M (+0.57 %) |